Evolent Health, Inc.
Congressional Trades
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Greg GianforteHouse · R · MT |
EVHEvolent Health, Inc. · Stock |
Sale $50,001 - $100,000 |
May 29, 2020 | May 11, 2020 | Filing ↗ |
Greg GianforteHouse · R · MT |
EVHEvolent Health, Inc. · Stock |
Purchase $100,001 - $250,000 |
Nov 27, 2019 | Oct 11, 2019 | Filing ↗ |
Greg GianforteHouse · R · MT |
EVHEvolent Health, Inc. · Stock |
Sale $50,001 - $100,000 |
Oct 20, 2019 | Sep 10, 2019 | Filing ↗ |
Greg GianforteHouse · R · MT |
EVHEvolent Health, Inc. · Stock |
Purchase $15,001 - $50,000 |
Jan 23, 2019 | Dec 20, 2018 | Filing ↗ |
Greg GianforteHouse · R · MT |
EVHEvolent Health, Inc. · Stock |
Purchase $50,001 - $100,000 |
Jun 15, 2018 | Jun 7, 2018 | Filing ↗ |
Greg GianforteHouse · R · MT |
EVHEvolent Health, Inc. · Stock |
Purchase $15,001 - $50,000 |
Feb 8, 2018 | Jan 29, 2018 | Filing ↗ |
Greg GianforteHouse · R · MT |
EVHEvolent Health, Inc. · Stock |
Sale $15,001 - $50,000 |
Jan 4, 2018 | Dec 29, 2017 | Filing ↗ |
Whale Activity
- Increased67
- New28
- Held27
- Decreased63
- Closed31
- No prior filing8
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 15.8M | $55.1M | increased |
| Rubicon Founders LLC | 5.6M | $19.7M | decreased |
| MARSHALL WACE, LLP | 5.3M | $18.6M | increased |
| Engaged Capital LLC | 5.0M | $17.6M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.7M | $16.3M | decreased |
| Nuveen, LLC | 3.9M | $13.6M | increased |
| TWO SIGMA INVESTMENTS, LP | 3.4M | $11.9M | increased |
| D. E. Shaw & Co., Inc. | 3.4M | $11.8M | decreased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.3M | $11.7M | increased |
| NOMURA HOLDINGS INC | 3.0M | $10.5M | new |
| GLENMEDE TRUST CO NA | 1.2M | $10.0M | new |
| STATE STREET CORP | 2.5M | $8.8M | increased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| McCarthy Daniel JosephPRESIDENT | Sale | −65.9K | $5.00 | $329K | Aug 26, 2026 | Form 4 ↗ |
| Weinberg JonathanGeneral Counsel | Tax withholding | −2,650 | $5.74 | $15K | Jul 1, 2026 | Form 4 ↗ |
| Weinberg JonathanGeneral Counsel | Grant / award | +43.1K | $0.00 | $0 | Jul 1, 2026 | Form 4 ↗ |
| Blackley SethChief Executive Officer · Director | Tax withholding | −10.3K | $5.74 | $59K | Jul 1, 2026 | Form 4 ↗ |
| Blackley SethChief Executive Officer · Director | Grant / award | +446.1K | $0.00 | $0 | Jul 1, 2026 | Form 4 ↗ |
| McCarthy Daniel JosephPRESIDENT | Tax withholding | −4,582 | $5.74 | $26K | Jul 1, 2026 | Form 4 ↗ |
| McCarthy Daniel JosephPRESIDENT | Grant / award | +302.6K | $0.00 | $0 | Jul 1, 2026 | Form 4 ↗ |
| Shams AammaadChief Accounting Officer | Grant / award | +28.8K | $0.00 | $0 | Jul 1, 2026 | Form 4 ↗ |
| Ajayi ToyinDirector | Grant / award | +41.1K | $0.00 | $0 | Jun 4, 2026 | Form 4 ↗ |
| Glass Russell MonroeDirector | Grant / award | +41.1K | $0.00 | $0 | Jun 4, 2026 | Form 4 ↗ |
| GRUA PETER JDirector | Grant / award | +41.1K | $0.00 | $0 | Jun 4, 2026 | Form 4 ↗ |
| GUERTIN SHAWN MDirector | Grant / award | +41.1K | $0.00 | $0 | Jun 4, 2026 | Form 4 ↗ |
| Jelinek Richard MDirector | Grant / award | +41.1K | $0.00 | $0 | Jun 4, 2026 | Form 4 ↗ |
| KECK KIMDirector | Grant / award | +41.1K | $0.00 | $0 | Jun 4, 2026 | Form 4 ↗ |
| Smith Jill D.Director | Grant / award | +41.1K | $0.00 | $0 | Jun 4, 2026 | Form 4 ↗ |
| Springstubb Brendan BDirector | Grant / award | +41.1K | $0.00 | $0 | Jun 4, 2026 | Form 4 ↗ |
| Barbarosh Craig A.Director | Grant / award | +41.1K | $0.00 | $0 | Jun 4, 2026 | Form 4 ↗ |
| Weinberg JonathanGeneral Counsel | Tax withholding | −8,275 | $3.51 | $29K | Mar 3, 2026 | Form 4 ↗ |
| Blackley SethChief Executive Officer · Director | Tax withholding | −24.1K | $3.51 | $84K | Mar 3, 2026 | Form 4 ↗ |
| McCarthy Daniel JosephPRESIDENT | Tax withholding | −24.0K | $3.51 | $84K | Mar 3, 2026 | Form 4 ↗ |
Fund Holders
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3.4M | $18.3M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 3.0M | $16.0M | 0.02% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.3M | $7.0M | 0.01% | Jun 30, 2026 |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 1.5M | $6.5M | 0.12% | Aug 31, 2026 |
| Nuveen Quant Small Cap Equity Fund TIAA-CREF Funds | 1.4M | $4.4M | 0.11% | Jul 31, 2026 |
| Schwab Fundamental U.S. Small Company ETF SCHWAB STRATEGIC TRUST | 914.1K | $4.1M | 0.05% | Aug 31, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 1.3M | $3.9M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF iShares Trust | 688.0K | $3.7M | 0.03% | Jun 30, 2026 |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 574.0K | $3.1M | 0.00% | Jun 30, 2026 |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 655.8K | $3.0M | 0.02% | Aug 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list EVH's shares (CUSIP 30050B101), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
- Eric BannaschSCHEDULE 13G/A · passive (13G) · 509.5K shares0.5%
Nov 16, 2026 · ↗ - Cadian Capital Management GP, LLCSCHEDULE 13G/A · passive (13G) · 509.5K shares0.5%
Nov 16, 2026 · ↗ - Cadian Capital Management, LPSCHEDULE 13G/A · passive (13G) · 509.5K shares0.5%
Nov 16, 2026 · ↗ - Boehler AdamSCHEDULE 13G/A · passive (13G) · 5.6M shares5.0%
Nov 13, 2026 · ↗ - Rubicon Founders LLCSCHEDULE 13G/A · passive (13G) · 5.6M shares5.0%
Nov 13, 2026 · ↗ - Rubicon OP GP II LLCSCHEDULE 13G/A · passive (13G) · 5.6M shares5.0%
Nov 13, 2026 · ↗ - Rubicon OP GP II LPSCHEDULE 13G/A · passive (13G) · 5.6M shares5.0%
Nov 13, 2026 · ↗ - Rubicon Fund II PF LPSCHEDULE 13G/A · passive (13G) · 693.7K shares0.6%
Nov 13, 2026 · ↗ - Rubicon Fund II LPSCHEDULE 13G/A · passive (13G) · 4.9M shares4.4%
Nov 13, 2026 · ↗ - Morgan Stanley Capital Services LLCSCHEDULE 13G/A · passive (13G) · 2.9M shares2.5%
Sep 8, 2026 · ↗
Corporate Lobbying
No lobbying filings found naming Evolent Health, Inc. as the client.
Government Contracts
No federal contract awards found for Evolent Health, Inc..
U.S. Patents
No USPTO patent applications found for Evolent Health, Inc..
Annual Financials
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.88B | $2.55B | $1.96B | $1.35B | $908.0M |
| Operating income | -$410.1M | -$40.5M | -$71.2M | $3.6M | -$42.4M |
| Net income | -$534.5M | -$61.6M | -$113.0M | -$19.2M | -$37.6M |
| Diluted EPS | -$5.07 | -$0.81 | -$1.28 | -$0.20 | -$0.44 |
| Operating cash flow | $38.8M | $18.8M | $142.6M | -$11.6M | $38.7M |
| Cash and equivalents | $151.9M | $104.2M | $192.8M | $188.2M | $266.3M |
| Total assets | $1.90B | $2.54B | $2.68B | $1.82B | $1.42B |
| Total liabilities | $1.48B | $1.35B | $1.43B | $957.9M | $725.8M |
| Shareholders' equity | $415.2M | $1.00B | $1.07B | $859.4M | $693.6M |
As Evolent Health, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 25, 2026 ↗
Stock Splits
No stock splits in EVH's price history.

